JACK H. DEAN - 06 Jan 2025 Form 4 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
Director
Signature
/s/ Kostantinos Skordalos, Power of Attorney For: Jack H. Dean
Issuer symbol
ACXP
Transactions as of
06 Jan 2025
Transactions value $
$10,000
Form type
4
Filing time
08 Jan 2025, 16:30:11 UTC
Previous filing
18 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACXP Common Stock Purchase $9,999 +9,852 +82.62% $1.02 21,776 06 Jan 2025 Direct F1
holding ACXP Common Stock 5,770 06 Jan 2025 By Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACXP Warrants for Common Stock Purchase $0 +9,852 $0 9,852 06 Jan 2025 Common Stock 9,852 $0.9 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired at the offering price in a registered direct offering of common stock by Acurx Pharmaceuticals, Inc.
F2 Shares held by the Dean Family Trust. The reporting person is the Trustee of the Dean Family Trust.
F3 Acquired in a concurrent private placement of warrants by Acurx Pharmaceuticals, Inc. in connection with the registered direct offering of common stock.